SMARCD3 and cancer: GSEA results showed that SMARCD3 expression was associated with cancer metastasis, TGF-β pathway activation and epithelial-mesenchymal transition (EMT) (Figure 7, p < 0.0001, TCGA colorectal cancer RNAseq data, N = 592).